Incomprehensible amounts of data are collected by all sectors of the healthcare industry on a daily basis. It is important for organizations to not only understand how to handle and collect this data, but also to translate it into actionable information that can help transform healthcare delivery. Unfortunately, many pitfalls still exist, and there is a need for better processes to collect clinically relevant and more complete data.
Incomprehensible amounts of data are collected by all sectors of the healthcare industry on a daily basis. It is important for organizations to not only understand how to handle and collect this data, but also to translate it into actionable information that can help transform healthcare delivery. On Tuesday afternoon at the AHIP Fall Forum 2012 conference, Ashish Jha, MD, MPH, associate professor of Health Policy and Management, Department of Health Policy and Mangement, Harvard School of Public Health, spoke about the need to improve the use of data and analytics to support healthcare delivery.
Dr Jha began his presentation by saying that we as a society don’t understand the social tradeoff that occurs because of inefficiencies in our healthcares system. He illustrated this point by talking about how his hometown of Newton, MA, recently reset their budget and had to lay off teachers because of rising healthcare costs. “Laying off teachers to pay for more MRIs is not a good social tradeoff,” said Dr Jha. He added that he is a researcher, analyst, and physician, and that, while he believes he is a better researcher and analyst than he was 10 years ago, he is unsure as to whether he is a better physician. His explanation was that, as a physician, he doesn’t receive nearly the feedback he does as a researcher or analyst. “The feedback loops are lacking,” he said, and mentioned that if he submits a research study to a journal and it is not accepted, he is given feedback as to why. Conversely, when he treats a patient for pneumonia, he may not receive any follow-up feedback at all.
Complicating things even further is the fact that much of the big data that exists in the healthcare industry today is not “good” data. Despite the fact that over a billion patient visits have been recorded via an electronic health record (EHR) this year, there are pitfalls that make it difficult to analyze this data in order to produce information that is clinically useful. There are a number of variables that are the cause of this issue. Interoperability exist when a hospitalist sees a patient that was previously treated at another hospital; depending on whether the technologies between these hospitals sync up, the patient’s information could either be readily available or completely nonexistent. Some hospitals are more technologically advanced than others, whereas many still rely on nurses to input patient information manually, which leads to human errors. In many cases, healthcare data are incomplete, and this is many times caused by the overwhelming amounts of EHRs that have different templates and several different methods to enter information. All of these variables can lead to massive amounts of data that aren’t helpful.
Dr Jha mentioned some solutions for making big data more relevant. He explained that there needs to be a change in the data requirements necessary for billing. In order to “fill in the gaps,” payers must become more involved, as they are often the source for incomplete data, according to Dr Jha.
It may be another 10 to 15 years before issues like interoperability are improved to the point where many of the aforementioned pitfalls can be avoided. However, in the meantime, if providers and payers can work together to come up with more consistent ways to collect data, the result will be more clinical relevance and improved healthcare delivery.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
The IRA’s Unintended Consequences for Drug Pricing and Coverage
April 2nd 2025The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Read More